A Specialized Diet for Multiple Sclerosis
NCT07033975 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2025-06-24
Summary
This study examines the impact of a Mediterranean diet on individuals with multiple sclerosis (MS). MS is a multifactorial disease in which environmental factors, such as nutrition, can influence disease progression. Therefore, this study aims to investigate whether a healthier dietary pattern, specifically a flavonoid-rich Mediterranean diet, can affect disease parameters.
Conditions
Interventions
- OTHER
-
Flavonoid-enriched Mediterranean Diet
A set of dietary guidelines describing an adjusted Mediterranean diet focusing on the intake of flavonoid-rich products.
Sponsors & Collaborators
-
Revalidatie & MS Centrum Overpelt
collaborator OTHER -
Jerome J. A. Hendriks
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-04
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
Multiple Sclerosis and the Effects of Ketogenic Diet Therapy
NCT06715436 ·Status: RECRUITING ·Phase: NA
-
A Study of the MIND Diet for Persons With Multiple Sclerosis
NCT06992115 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis
NCT02008669 ·Status: COMPLETED
-
Investigation of the Effect of the MIND Diet on Disease Symptoms in Patients With MS
NCT07057999 ·Status: COMPLETED ·Phase: NA
-
Relationship Between the Nutritional Habits and Relapsing and Disability Rates in Patient With Multiple Sclerosis.
NCT04110171 ·Status: UNKNOWN
-
Assessment of Walking-related Fatigability in Patients With Multiple Sclerosis.
NCT03860675 ·Status: COMPLETED ·Phase: NA
-
Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis
NCT02133664 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Utilization of the Ketogenic Diet in Patient With Relapsing Remitting MS
NCT03718247 ·Status: COMPLETED
-
Low Fat Diet and Multiple Sclerosis
NCT00852722 ·Status: COMPLETED ·Phase: PHASE1
-
Melatonin in Patients With Multiple Sclerosis (MS).
NCT03498131 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)
NCT01188811 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Protection Against Severe Coronavirus Disease 2019 in Patients With Multiple Sclerosis Stratified According to Disease Modifying Treatment
NCT05834335 ·Status: COMPLETED
-
Prescription Drug Safety and Effectiveness in Multiple Sclerosis
NCT04472975 ·Status: COMPLETED
-
The Effect of a Series of Systemic Cryotherapy Treatments on the Functional State of Patients With Multiple Sclerosis
NCT04533971 ·Status: COMPLETED ·Phase: NA
-
Effect of MD1003 in Spinal Progressive Multiple Sclerosis
NCT02220933 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis
NCT01433497 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis
NCT03172741 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis (Feasibility Study)
NCT04057066 ·Status: COMPLETED ·Phase: NA
-
Development and Evaluation of a Web-based Programme on Relapse Management for People With Multiple Sclerosis
NCT04233970 ·Status: COMPLETED ·Phase: NA
-
Multiple Sclerosis: Associated Cardiometabolic Risks and Impact of Exercise Therapy
NCT02466165 ·Status: COMPLETED ·Phase: NA
-
Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression
NCT03368677 ·Status: ACTIVE_NOT_RECRUITING
-
Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis
NCT04367389 ·Status: COMPLETED ·Phase: NA
-
Exercise-based Therapy for Multiple Sclerosis Patients
NCT03735524 ·Status: UNKNOWN ·Phase: NA
-
Simvastatin in Secondary Progressive Multiple Sclerosis
NCT03896217 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Study on the Role of SCFA Modulation in Multiple Sclerosis
NCT06746896 ·Status: ACTIVE_NOT_RECRUITING